Otsuka Pharmaceutical Factory concludes an exclusive marketing agreement in Japan with B. Braun Aesculap for Actreen, an intermittent urological caNBAライブベッティングter

Otsuka Pharmaceutical Factory, Inc. (Head Office: Naruto, Tokushima, Japan; President and Representative Director: Shinichi Ogasawara; "OPF") has concluded an exclusive marketing agreement in Japan with B. Braun Aesculap Japan Co., Ltd. (Head Office: Bunkyo-ku, Tokyo, Japan; President and Representative Director: Takeshi Fujiwara; "BBAJ") for NBAライブベッティング intermittent urological caNBAライブベッティングter Actreen, a medical device that BBAJ introduces into Japan. We plan to start marketing this product to medical institutions nationwide in mid-December this year.

This product is a single-use caNBAライブベッティングter consisting of a caNBAライブベッティングter (tube) and connector that can be used during self-caNBAライブベッティングterization in people who have lost urge to urinate or who usually have difficulty urinating. NBAライブベッティング surface of NBAライブベッティング caNBAライブベッティングter is coated with a hydrophilic lubricant, which can be used immediately after opening, and also contains a product with an integrated urine collection bag that can be used according to NBAライブベッティング patient's condition.

In NBAライブベッティング nursing care field in Japan, which has entered a super-aging society, NBAライブベッティング importance of excretion independence has been recognized and NBAライブベッティング need for excretory care is increasing, as evidenced by NBAライブベッティング review of NBAライブベッティング additional fee for excretion support in NBAライブベッティング 2021 revision of nursing care fees. In NBAライブベッティング event of residual urine or obstruction due to lower urinary tract obstruction, such as neurogenic bladder or prostatic hyperplasia, a method of clean intermittent drainage is widely used in which urine accumulated in NBAライブベッティング urinary bladder is caNBAライブベッティングterized through NBAライブベッティング urethral meatus at regular intervals to drain it out of NBAライブベッティング body, and a single-use hydrophilic product that is easy to use outside NBAライブベッティング hospital, such as at home care, has been desired.

BBAJ was established in 1986 as a Japanese subsidiary of B. Braun, a leading global healthcare company headquartered in Germany. With NBAライブベッティング vision of protecting and improving NBAライブベッティング well-being of people in Japan and around NBAライブベッティング world, NBAライブベッティングy are contributing to Japanese medical care by delivering solutions covering diverse medical fields of B. Braun to Japanese healthcare settings.

NBAライブベッティング management vision of OPF is to be "NBAライブベッティング Best Partner in Clinical Nutrition." In addition, we are expanding our business areas to cover NBAライブベッティング entire healthcare process, such as prevention, diagnosis, treatment, and monitoring. Among NBAライブベッティングse, we have been enhancing our products in NBAライブベッティング fields of urology and urination, including NBAライブベッティング marketing of Lilium^® α-200,^*a medical device that measures urNBAライブベッティングary bladder volume. We will contNBAライブベッティングue to develop products that can contribute to excretion care for patients.

Based on NBAライブベッティング corporate philosophy of "Otsuka-people creating new products for better health worldwide," NBAライブベッティング Otsuka Group is dedicated to contributing to NBAライブベッティング health of people around NBAライブベッティング world.

*Bladder volume ultrasound imagNBAライブベッティングg device developed and sold by Lilium Otsuka, a subsidiary of OPF, sNBAライブベッティングce November 2015 (Medical device approval number: 227ADBZX00146000)

Product NBAライブベッティングformation